Health ❯Healthcare ❯Drug Safety

Adverse Effects

Stock Market Financial News Pharmaceutical Industry Medication Adherence Drug Safety Market Analysis Alzheimer's Disease Drug Competition Research Studies Neurology

4 ARTICLES

3w ago

Amgen’s MariTide Delivers 20% Weight Loss in Phase 2 and Advances to 72-Week Phase 3 Trial

Amgen plans a 72-week pivotal study following phase 2 results that showed substantial weight loss alongside lower gastrointestinal side effects from a low-dose ramp-up.

5 ARTICLES

3mo ago

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns